Sulphonamide derivatives as .alpha..sub.2 -adrenoceptor antagoni

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546 62, 546 70, A61K 31435, C07D47114, C07D491147, C07D49514

Patent

active

047882026

ABSTRACT:
The invention concerns sulphonamides of general formula ##STR1## and their pharmaceutically acceptable acid addition salts. In formula (I), R represents hydrogen or lower alkyl, R.sup.1 and R.sup.2 which may be the same or different each represents hydrogen, lower alkyl, lower alkoxy or halogen, R.sup.3 and R.sup.4 which may be the same or different each represents lower alkyl, halo(lower)alkyl or aryl, A represents a lower alkylene group having 1 to 3 carbon atoms in the chain between the two N atoms and X represents O, S or NR.sup.5 (where R.sup.5 is hydrogen or lower alkyl). The compounds possess .alpha..sub.2 -adrenoceptor antagonistic activity in warm blooded animals.

REFERENCES:
patent: 4640924 (1987-02-01), White et al.
patent: 4686226 (1987-08-01), Huff et al.
patent: 4690928 (1987-09-01), Huff et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Sulphonamide derivatives as .alpha..sub.2 -adrenoceptor antagoni does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sulphonamide derivatives as .alpha..sub.2 -adrenoceptor antagoni, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulphonamide derivatives as .alpha..sub.2 -adrenoceptor antagoni will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-363750

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.